Continuous smoking and progression of arterial stiffening: A prospective study

Journal of the American College of Cardiology

Volumn 55, Issue 18, 2010, Pages 1979-1987

  Tomiyama, Hirofumi ^a   Hashimoto, Hideki ^b   Tanaka, Hirofumi ^c   Matsumoto, Chisa ^a   Odaira, Mari ^a   Yamada, Jiko ^a   Yoshida, Masanobu ^a   Shiina, Kazuki ^a   Nagata, Mikio ^d   Yamashina, Akira ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^d KAJIMA CORPORATION   (Japan)

Author keywords

Arteriosclerosis; Inflammation; Pulse wave velocity; Risk factors; Tobacco

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; C REACTIVE PROTEIN;

ADULT; ANKLE BRACHIAL INDEX; ARTERIAL STIFFNESS; ARTERITIS; ARTICLE; C REACTIVE PROTEIN BLOOD LEVEL; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTINUOUS SMOKING; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PULSE WAVE; SMOKING; SMOKING HABIT; AGE; ARTERY; BLOOD; ELASTICITY; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; STATISTICAL MODEL;

ADULT; AGE FACTORS; ANKLE BRACHIAL INDEX; ARTERIES; C-REACTIVE PROTEIN; DISEASE PROGRESSION; ELASTICITY; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SMOKING;

EID: 77952300667     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.12.042     Document Type: Article

References (31)

1. Safar ME, Levy BI, Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation 2003;107:2864-9.
2. O'Rourke MF, Hashimoto J. Mechanical factors in arterial aging: a clinical perspective. J Am Coll Cardiol 2007;50:1-13.
3. Laurent S, Boutouyrie P. Recent advances in arterial stiffness and wave reflection in human hypertension. Hypertension 2007;49:1202-6.
4. Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol 2004;43:1731-7.
5. Edwards R. The problem of tobacco smoking. BMJ 2004;328:217-9.
6. Rhee MY, Na SH, Kim YK, Lee MM, Kim HY. Acute effects of cigarette smoking on arterial stiffness and blood pressure in male smokers with hypertension. Am J Hypertens 2007;20:637-41.
7. Stefanadis C, Tsiamis E, Vlachopoulos C, et al. Unfavorable effect of smoking on the elastic properties of the human aorta. Circulation 1997;95:31-8.
8. Jatoi NA, Jerrard-Dunne P, Feely J, Mahmud A. Impact of smoking and smoking cessation on arterial stiffness and aortic wave reflection in hypertension. Hypertension 2007;49:981-5.
9. Sassalos K, Vlachopoulos C, Alexopoulos N, Gialernios T, Aznaouridis K, Stefanadis C. The acute and chronic effect of cigarette smoking on the elastic properties of the ascending aorta in healthy male subjects. Hellenic J Cardiol 2006;47:263-8.
10. Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF. Systemic effects of smoking. Chest 2007;131:1557-66.
11. Tomiyama H, Hashimoto H, Hirayama Y, et al. Synergistic acceleration of arterial stiffening in the presence of raised blood pressure and raised plasma glucose. Hypertension 2006;47:180-8.
12. Japan Atherosclerosis Society. [Guidelines for diagnosis and treatment of atherosclerotic cardiovascular diseases]. Tokyo, Japan: Life Science Publishing, 2000:4-21.
13. Hata Y, Mabuchi H, Saito Y, et al., Working Committee on JAS Guideline for Diagnosis and Treatment of Hyperlipidemias. Report of the Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Treatment of Hyperlipidemia in Japanese adults. J Atheroscler Thromb 2002;9:1-27.
14. Teramoto T, Sasaki J, Ueshima H, et al. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese. J Atheroscler Thromb 2007;14:45-50.
15. Japan Diabetes Society. [Guidelines for diagnosis of diabetes mellitus]. J Jpn Diabetes Soc 1999;42:385-404.
16. Japanese Society of Hypertension. [Guidelines for the management of hypertension]. Tokyo, Japan: Japanese Society of Hypertension, 2000: 14-21.
17. Japanese Society of Hypertension. [Guidelines for the management of hypertension]. Tokyo, Japan: Japanese Society of Hypertension, 2004: 7-34.
18. Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003;107:1514-9.
19. Yamashina A, Tomiyama H, Takeda K, et al. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 2002;25:359-64.
20. Tomiyama H, Okazaki R, Koji Y, et al. Elevated C-reactive protein: a common marker for atherosclerotic cardiovascular risk and subclinical stages of pulmonary dysfunction and osteopenia in a healthy population. Atherosclerosis 2005;178:187-92.
21. Wannamethee SG, Shaper AG, Walker M, Ebrahim S. Lifestyle and 15-year survival free of heart attack, stroke, and diabetes in middleaged British men. Arch Intern Med 1998;158:2433-40.
22. Jee SH, Suh I, Kim IS, Appel LJ. Smoking and atherosclerotic cardiovascular disease in men with low levels of serum cholesterol: the Korea Medical Insurance Corporation Study. JAMA 1999;282:2149-55.
23. Baldassarre D, Castelnuovo S, Frigerio B, et al. Effects of timing and extent of smoking, type of cigarettes, and concomitant risk factors on the association between smoking and subclinical atherosclerosis. Stroke 2009;40:1991-8.
24. Song YM, Cho HJ. Risk of stroke and myocardial infarction after reduction or cessation of cigarette smoking: a cohort study in Korean men. Stroke 2008;39:2432-8.
25. Guo X, Oldham MJ, Kleinman MT, Phalen RF, Kassab GS. Effect of cigarette smoking on nitric oxide, structural, and mechanical properties of mouse arteries. Am J Physiol Heart Circ Physiol. 2006;291:H2354-61.
26. Jialal I, Devaraj S, Venugopal SK. C-reactive protein: risk marker or mediator in atherothrombosis? Hypertension 2004;44:6-11.
27. Schumacher W, Cockcroft J, Timpson NJ, et al. Association between C-reactive protein genotype, circulating levels, and aortic pulse wave velocity. Hypertension 2009;53:150-7.
28. Sugawara J, Hayashi K, Yokoi T, et al. Brachial-ankle pulse wave velocity: an index of central arterial stiffness? J Hum Hypertens 2005;19:401-6.
29. Tomiyama H, Koji Y, Yambe M, et al. Brachial -ankle pulse wave velocity is a simple and independent predictor of prognosis in patients with acute coronary syndrome. Circ J 2005;69:815-22.
30. Kitahara T, Ono K, Tsuchida A, et al. Impact of brachial-ankle pulse wave velocity and ankle-brachial blood pressure index on mortality in hemodialysis patients. Am J Kidney Dis 2005;46:688-96.
31. Gorber SC, Schofield-Hurwitz S, Hardt J, Levasseur G, Tremblay M. The accuracy of self-reported smoking: a systematic review of the relationship between self-reported and cotinine-assessed smoking status. Nicotine Tob Res 2009;11:12-24.